Drive Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $556K | Buy |
1,249
+176
| +16% | +$78.3K | 0.12% | 149 |
|
|
2025
Q1 | $520K | Sell |
1,073
-48
| -4% | -$23.3K | 0.12% | 135 |
|
|
2024
Q4 | $451K | Buy |
1,121
+12
| +1% | +$4.83K | 0.11% | 146 |
|
|
2024
Q3 | $516K | Buy |
1,109
+8
| +0.7% | +$3.72K | 0.13% | 124 |
|
|
2024
Q2 | $516K | Buy |
1,101
+22
| +2% | +$10.3K | 0.14% | 128 |
|
|
2024
Q1 | $451K | Buy |
1,079
+8
| +0.7% | +$3.34K | 0.13% | 151 |
|
|
2023
Q4 | $436K | Buy |
1,071
+50
| +5% | +$20.3K | 0.14% | 136 |
|
|
2023
Q3 | $355K | Buy |
1,021
+91
| +10% | +$31.6K | 0.13% | 151 |
|
|
2023
Q2 | $327K | Buy |
930
+100
| +12% | +$35.2K | 0.12% | 161 |
|
|
2023
Q1 | $262K | Buy |
+830
| New | +$262K | 0.11% | 201 |
|